Trial Profile

Study of mRNA 3705 in Methylmalonic acidaemia patients

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 12 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MRNA-3705 (Primary)
Indications Methylmalonic acidaemia
Focus Registrational; Therapeutic Use

Most Recent Events

01 May 2026 According to a Moderna Therapeutics media release,The Company is deferring its decision on a pivotal trial for mRNA-3705 until PA registrational data readout.
20 Nov 2025 According to a Moderna Therapeutics media release, study expected to begin in 2026.
01 May 2025 According to a Moderna Therapeutics media release, The Company expects to start a registrational study in 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com